Emergent Biosolutions Inc (EBS)
EBITDA
-$700.00K
TTM · Period ending: · USD
EBS EBITDA
Latest reported-$700.00Kperiod ending
Latest reported-$700.00Kperiod ending
EBS TTM EBITDA (-$386.30M → -$700.00K)
TTM EBITDA
High-resolution chart · PNG
EBS ebitda history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | EBITDA (USD) |
|---|---|
| -700,000 | |
| 153,000,000 | |
| 237,900,000 | |
| 272,100,000 | |
| 274,300,000 | |
| 122,300,000 | |
| 53,800,000 | |
| 19,500,000 | |
| -54,500,000 | |
| 125,000,000 | |
| -42,300,000 | |
| 8,900,000 | |
| -28,000,000 | |
| -106,900,000 | |
| 33,900,000 | |
| 343,900,000 | |
| 355,300,000 | |
| 434,300,000 | |
| 521,700,000 | |
| 460,500,000 | |
| 580,700,000 | |
| 686,300,000 | |
| 578,300,000 | |
| 399,400,000 | |
| 378,700,000 | |
| 245,600,000 | |
| 227,800,000 | |
| 163,194,000 | |
| 98,494,000 | |
| 156,194,000 | |
| 159,594,000 | |
| 187,915,000 | |
| 212,686,000 | |
| 152,146,000 | |
| 174,822,000 | |
| 169,547,000 | |
| 160,688,000 | |
| 148,916,001 | |
| 154,237,001 | |
| 171,746,001 | |
| 193,854,001 | |
| 235,651,000 | |
| 186,676,000 | |
| 163,114,000 | |
| 131,418,000 | |
| 99,054,000 | |
| 99,021,000 | |
| 74,851,000 | |
| 58,149,000 | |
| 60,749,000 | |
| 69,773,000 | |
| 57,604,000 | |
| 46,869,000 | |
| 40,073,000 | |
| 39,974,000 | |
| 63,617,000 | |
| 54,909,000 | |
| 65,255,000 | |
| 41,304,000 | |
| 30,065,000 | |
| 48,203,000 | |
| 40,919,000 | |
| 79,010,000 | |
| 47,870,000 | |
| 23,504,000 | |
| 32,567,000 | |
| 46,517,000 | |
| 42,976,000 | |
| 60,663,000 | |
| 40,807,000 | |
| 34,910,000 | |
| 77,017,000 | |
| 66,101,000 | |
| 54,184,000 | |
| 36,644,000 | |
| 37,615,000 | |
| 43,391,000 | |
| 72,862,000 | |
| 99,443,000 | |
| 15,105,000 | |
| 33,874,000 | |
| 40,893,000 | |
| 47,912,000 | |
| 37,232,000 | |
| 29,139,000 | |
| 21,046,000 | |
| 12,953,000 | |
| -2,478,000 | |
| -58,052,000 | |
| -371,826,000 | |
| -386,300,000 | |
| -386,300,000 |